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Abstract 
There is growing interest in discrete-choice experiments (DCE) as a method to elicit consumers' 
preferences in the health care sector. Increasingly this method is used to determine willingness-to-pay 
(WTP) for health-related goods. However, its external validity in the health care domain has not been 
investigated until today. This paper examines the external validity of DCE concerning the reduction of 
a health risk. Convergent validity is examined by comparing the value of a statistical life with other 
preference elicitation techniques, such as revealed preference. Criterion validity is shown by 
comparing WTP values derived from stated choices in the experiment with those derived from actual 
choices made by the same individuals. Both tests provide strong evidence in favor of external validity 
of the DCE method. 
JEL Classification Numbers: C25, C52, D12, I18, I19 
Keywords: Discrete-Choice Experiments (DCE), Willingness-to-Pay (WTP), Validity, Risk 
Reduction, Hip Protectors. 
                                                                                                                                                        
* Financial support by the Swiss Council for Accident Prevention (CAP) is gratefully acknowledged. Also, 
authors wouold like to thank two anonymous referees for their perceptive comments and criticisms. 
 3 
1 Introduction 
Discrete-choice experiments (DCE) are designed to allow individuals to express their 
preferences for non-marketed goods or goods which do not exist yet. They have become very 
popular in transportation economics (Hensher, 1997) and environmental economics 
(Adamowicz und Boxall, 2001). Recently, there have been several applications of DCE in the 
health domain (for a survey see Ryan and Gerard, 2003). However, being hypothetical, DCE 
are subject to the criticism that they may fail to be related to (and ultimately predict) actual 
choices. Outside health, Louviere and Woodsworth (1983) have presented evidence 
suggesting that DCE can be used to explain modal choice in transportation, while Ghosh 
(1986) has found that they contribute to explaining the choice of a shopping mall. DCE with 
regard to health have so far been hardly related to actual choices (Ryan, 2004; Ryan and 
Gerard, 2003). 
The present contribution seeks to fill this gap, and in a context that may be deemed 
particularly difficult because one of the product attributes distinguished is risk reduction. It is 
well known that probabilities and changes in probabilities pose particular problems in surveys 
and experiments. The specific product in question is a hip protector that serves to all but 
eliminate the risk of fracture of the femur in aged persons. With an estimated mortality of up 
to 20 percent (Dubey et al., 1998) and treatment cost around US$ 30,000 per case and year 
(Barefield, 1996), fractures of the femur are far from trivial. Therefore, their prevention is of 
some economic interest; on the other hand, hip protectors must be worn to be effective. This 
study relates willingness-to-pay (WTP) values estimated in a DCE (the stated choice) to the 
same respondents’ later willingness to participate in a wearing trial of two months’ duration 
(the actual choice). In this way, this study is likely to be the first in the health domain to 
confront results from a DCE with actual choices. 
In section 2, the issues of reliability and validity as quality attributes of DCE are discussed in 
a review of the literature. In section 3, the methods used in the present DCE for establishing 
relevant product attributes and estimating marginal willingness-to-pay (MWTP) are 
described. Results with regard to convergent and criterion validity of DCEs are presented in 
section 4. Section 5 contains a discussion and conclusion. 
2 Reliability and validity of DCE results 
In the course of a DCE, respondents are confronted with a sequence of product varieties with 
changing product attributes. In each case, they are asked to indicate which of the presented 
varieties they prefer. In this way an indifference hyperplane in attribute space is 
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approximated. Since one of the attributes is out-of-pocket price, the marginal rate of 
substitution between a particular attribute and price indicates the marginal willingness-to-pay 
(MWTP) for that attribute. The WTP for the product as a whole can be determined by 
integrating the MWTP values up to the corresponding attribute levels and aggregating 
(Johnson and Desvousges, 1997). 
Following Jöreskog and Goldberger (1975) (see also Schoenberg and Arminger, 1989), let y1 
and y2 denote two measurements of a latent variable X. Since the determinants of X (neglected 
in eq. (1) below for simplicity) may change between the two observations, X in general will 
have unobserved values X1 and X2. However, measurements may be contaminated by an 
irrelevant latent variable Z. In the present context, y1 and y2 are ‘observed’ (calculated) WTP 
values that depend on a latent quantity X (such as marginal rate of substitution) that may 
differ between subsamples (X1 ≠ X2); however, they by hypothesis should not be a function of 
e.g. political attitudes Z. Then, observations are generated according to the measurement 
model 
 
222222111111      , eZXyeZXy ++=++= µλµλ , (1) 
 
with (λ1, µ1, λ2, µ2) denoting the loadings of measurements on latent variables and (e1, e2) 
stochastic i.i.d. error terms. There are several sources of systematic error. Relevant product 
attributes may not have been recognized (the X vector is too short to begin with), seemingly 
irrelevant attributes may have been excluded (the X vector has been erroneously shortened), 
or the underlying indirect utility function may have been wrongly specified (the structural 
model determining X is wrong). Random errors are always present; in DCE, they are even 
part of the specification, which is based on the random utility model. 
2.1 Reliability 
Reliability requires that measurements can be reproduced at least on average, which means 
that loadings should be constant (λ1 = λ2, µ1 = µ2) and random errors zero on expectation, 
. There are several ways to check for reliability (see e.g. Litwin, 1995): The 
test-retest method benefits from repeated measurement; in that case, eq. (1) applies directly. 
Parallel testing involves the simultaneous use of two slightly different instruments; in this 
case, y
( ) 0)( 21 == eEeE
1 and y2 are two different indicators, which should have loadings λ1 and λ2, that differ in 
a predictable way provided µ1 = µ2 = const. Finally, in the alternate-form method the sample is 
split, with part of the observations reserved for reestimation using a variant of the 
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measurement method. Here, y1 and y2 refer to the two segments of the sample that again 
should induce loadings λ1 and λ2 that deviate in a predictable way. 
DCE applied to health have but rarely been tested for reliability (Ryan and Gerard, 2003). A 
likely reason is that additional observations come at a steep marginal cost, causing sample 
size to be rather small to begin with. Nevertheless, Farrar and Ryan (1999) using the 
alternate-form method found that the sequence of presentation of attributes did not change the 
setting of priorities in hospitals. Bryan et al. (2000) used the test-retest procedure by asking 
the same persons about their preferences for treatment of knee injuries within two weeks. The 
authors found a high degree of conformity between the two DCE. Telser and Zweifel (2002) 
using the same data as presented here performed an out-of-sample test in a DCE dealing with 
fractures of the femur. They concluded that DCE are an instrument of high reliability for 
measuring WTP for the reduction of a health risk. 
2.2 Validity 
The validity requirement is more stringent, requiring not only λ1 = λ2 indicators, but also 
µ1 = µ2 = 0 in eq. (1) (λ1 ≠ λ2 or µ1 ≠ µ2 ≠ 0 only if the maintained hypothesis makes a 
prediction regarding the relative quality of the two indicators). Thus, not only must 
measurement be reliable but also free of systematic, uncontrolled bias that could be caused by 
a variable Z that is irrelevant by hypothesis. There are several types of validity (see again 
Litwin, 1995). Economists often distinguish between internal and external validity. Internal 
validity refers to (1) the rigor with which the study was conducted (e.g., the study's design, the 
care taken in conducting the interviews, and decisions concerning what was and what was not 
measured); it makes certain values of λ1 and λ2 credible; and (2) the extent to which the 
designers of a study have taken into account alternative explanations for any causal 
relationships they explore, for example by explicitly testing for an influence of Z. External 
validity refers to the generalizability of the results to other populations, settings, and 
circumstances; thus, it makes credible that λ1 = λ2 if the two values are estimated from two 
arbitrary samples or populations. In this paper we focus on two variants of external validity, 
viz. convergent and criterion validity. 
Convergent validity obtains if different methods that are designed to generate information 
about the same theoretical construct X have convergent results (y1, y2). In the present case, 
true WTP is the theoretical construct, which can be elicited e.g. by contingent valuation (CV), 
revealed preference (RP), and DCE methods. If DCE has convergent validity, the WTP values 
obtained should be similar to those elicited with the other methods, provided these benchmark 
methods constitute valid elicitation techniques; thus λ1 = λ2 although y1 and y2 are generated 
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by different methods. Criterion validity obtains if the results of a method correspond with an 
external criterion. For example, WTP calculated in a DCE can be compared to WTP observed 
in actual choices, which provide the external criterion; in this case, an alternative with a 
known value of λ is available. 
DCE for environmental goods have been tested for convergence validity. Thus, Mason and 
Quigley (1983) found that hedonic regression (where market prices are related to product 
attributes) resulted in estimates that were similar to those derived from DCE. The estimates of 
both methods were close to the ‘true’ values of a Monte Carlo simulation. A similar 
conclusion was drawn by Gegax and Stanley (1997) who compared WTP values for safety 
obtained from hedonic regression and DCE. They found no significant differences between 
the hedonic and DCE estimates. More recent results from environmental economics confirm 
convergence validity between RP and DCE (see e.g. Hensher et al., 1999; Louviere et al., 
1999). However, juxtaposing CV and DCE results, Boxall et al. (1996) arrived at WTP 
estimates that were twenty times higher in the case of CV. At the same time, these authors 
were able to show that DCE results were in conformity with RP, i.e. with actual choice 
behavior. Mark and Swait (2004) come to the same conclusion with regard to physicians’ 
evaluation of an alcohol medication and actual prescribing decisions.Still other studies cast 
doubt on the validity of the CV method (see, e.g., Hausman, 1993; Nocera et al., 2002) or 
suggest superiority of DCE over CV (Ryan, 2004) 
Outside health, the criterion validity of DCE has been tested on several occasions, causing 
Louviere (1988) to conclude that DCE constitute a valid instrument for explaining and 
predicting individual behavior on actual markets. More recently Carlsson and Martinsson 
(2001) observed that measured WTP for a public good did not differ much between a DCE 
with hypothetical payments and a subsequent DCE with real payments. However, in a control 
group that was only confronted with actual payments, WTP was substantially lower 
(Johansson-Stenman and Svedsäter, 2003). While this latter finding is not compatible with 
criterion validity, it may not carry over to private goods, to which a majority of health care 
services belong. In the context of health, the survey by Ryan and Gerard (2003) shows the 
validity of DCE to be still an open issue; specifically convergence and criterion validity seem 
not yet to have been tested. 
Conclusion 1: In contrast to environmental economics, discrete-choice experiments 
concerning health-related goods have been rarely checked for reliability 
and hardly for external validity, the latter involving convergent and 
criterion validity.  
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3 Methods 
For the present study, aged persons were interviewed in a pretest in order to establish the 
relevant product attributes of a hip protector. Following standard DCE procedures, the 
product attributes of such a hip protector were preliminarily assumed to be protective effect, 
wearing comfort, ease of handling, change of appearance, and out-of-pocket cost. In the 
pretest (N = 17), it turned out that the dimension ‘appearance’ was judged unimportant by a 
clear majority, justifying its exclusion from the main survey (see Telser and Zweifel, 2002 for 
details). The importance of the product attributes was again ascertained in the field survey. A 
majority of respondents judged all of the retained four attributes to be very important, notably 
the attribute ‘out-of-pocket cost’. This may be surprising in health care systems with 
comprehensive health insurance coverage. However, in Switzerland insureds are subject to a 
degree of cost sharing especially in ambulatory care. This also makes a decision situation 
involving out-of-pocket payment less hypothetical for respondents. The levels of the attributes 
were defined as follows (see Table 1). ‘Protective effect’ (PROT), symbolizing the risk 
reduction from an unknown individual level, takes on the values of 100, 75, and 50%. The 
choice of levels reflects the high effectiveness of existing variants of hip protectors (see e.g., 
Lauritzen et al., 1993; or Ekman et al., 1997). ‘Ease of handling’ (HAND) varies between 3 
(very easy to put on) and 1. The same holds for ‘wearing comfort’ (COMF). The ‘out-of-
pocket cost’ (COST) ranges from CHF 0 (which reflects the scenario of health insurance fully 
covering the hip protector in the future) to CHF 200 (US$ 133 at 1998 exchange rates), 
bracketing the price (CHF 80) typically paid by institutional purchasers. The reference 
scenario is the status quo (no purchase of hip protector). For a sample choice scenario, see the 
Appendix. 
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Table 1 Product attributes and levels retained in the main survey 
Attributes Label Levels Value labels 
Protective effect PROT 100% protection from hip fracture 
75% protection from hip fracture 
50% protection from hip fracture 
100 
75 
50 
Ease of handling HAND Handling is easy 
Handling is somewhat complicated 
Handling is very complicated 
3 
2 
1 
Wearing comfort COMF Comfortable to wear 
Somewhat uncomfortable to wear 
Uncomfortable to wear 
3 
2 
1 
Out-of-pocket cost COST CHF 0 (US$ 0) 
CHF 75 (US$ 50) 
CHF 150 (US$ 100) 
CHF 200 (US$ 133) 
0 
75 
150 
200 
 
Since the first three attributes have 3 levels each, while COST has 4, the number of possible 
scenarios amounts to a total of 108 (= 3*3*3*4). Techniques have been developed to reduce 
the number of possible scenarios while still being able to infer utilities for all combinations of 
levels of the attributes (see Louviere et al., 2000). Using the ORTHOPLAN procedure 
programmed in the software package SPSS, the design was reduced to 23 scenarios ensuring 
orhogonality w.r.t. main effects. These 23 variants were split into two (randomly presented) 
subsets featuring a different sequence of presentation of the hip protectors to avoid boredom 
and bias on the part of respondents. With regard to each variant, respondents had to indicate 
whether or not they would buy the product. 
The main survey consisted of 522 face-to-face interviews (of about 45 min length on average) 
with individuals aged 70 and older in the Summer of 1998. The sample is representative with 
regard to age and sex of the independently living Swiss subpopulation. At the end of the 
interview, participants in the survey were asked whether they were willing to take part in a 
wearing test of a specific hip protector (HIPS®) free of charge (COST = 0) which was carried 
out three months later. Before the trial, participants had to rate the product in terms of PROT, 
HAND, and COMF of HIPS®. The intentions stated in the last part of the interview can be 
interpreted as an actual choice because participants were expected to document their trial in a 
diary during three months. This provides the basis for the test of criterion validity of DCE 
presented in section 4.2. 
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4 Results 
4.1 Probit estimation 
The theoretical basis for estimation is provided by the random utility model (McFadden, 
1974) which assumes that the difference in the systematic component of utility must exceed 
the difference in its stochastic component for the individual to opt for the alternative rather 
than the status quo. Since the error term is assumed to be normally distributed, the difference 
is normally distributed as well, calling for Probit estimation. Since PROT, HAND, and 
COMF are categorically defined, a Wald test is used to determine whether their linear 
representation is admissible (for details, see Telser and Zweifel, 2002). Linearity need not to 
be rejected. Finally, since the same individuals made several choices, the data set has a panel 
structure. To reflect this fact, a random effects specification was chosen for the error term. 
Thus, iijije υη += , with iυ  denoting the individual-speficic component and ijη  the general, 
component of the error term that may also vary across scenarios. 
The estimation result is shown in Table 2 (= Table 4 in Telser and Zweifel, 2002). All product 
attributes retained are highly significant and have the expected signs. This provides some 
evidence in favor of criterion validity because attribute selection was based on an independent 
pretest. In addition, although protective effect (PROT) was defined in terms of probability, a 
concept many individuals are not very familiar with, it has a strongly significant positive 
effect on the propensity to opt for the alternative. The COST attribute has a negative and 
highly significant coefficient, a result that implies that inferences on WTP can safely be made. 
 
Table 2 Random effects probit estimates 
Variable Coefficient Std. err. z P > |z| 
Protective effect (PROT) 0.0141*** 0.0013 11.1 0.000 
Ease of handling (HAND) 0.3325*** 0.0313 10.6 0.000 
Wearing comfort (COMF) 0.6628*** 0.0361 18.4 0.000 
Out-of-pocket cost (COST) -0.0029*** 0.0003 -10.1 0.000 
CONSTANT -3. 9812*** 0.1868 -21.3 0.000 
Number of obs. 3714 
Chi2 (15)  569.31 
Prob > chi2 0.000 
Deviance  3269. 53 
Dispersion 0.8815 
ρ  0.1879 
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The coefficients shown in Table 2 can be used to calculate WTP values (details in Telser and 
Zweifel, 2002). For instance, the marginal WTP for 1 percentage point of risk reduction 
amounts to an estimated US$2.49 (s.e. 0.50) for individuals with a monthly income of less 
than US$2000 but US$5.00 (s.e.1.55) for individuals with US$2000 and more – a difference 
that is in keeping with microeconomic theory provided that protection against risk is a normal 
good (Zweifel and Breyer 1997, ch. 2). 
4.2 Convergent validity: value of a statistical life 
Willingness-to-pay for a marginal risk reduction can be extrapolated to obtain the value of a 
statistical life. For example, the estimates cited at the end of the preceding paragraph would 
suggest that to low-income individuals in Switzerland, eliminating the risk of breaking the 
femur entirely is worth US$249 and to those with monthly incomes above US$2000, about 
US$500, among individuals aged 70 and over. Breaking the hip being lethal with a certain 
probability, values of a statistical life can be deduced from these figures (see below). Since 
CV as well as RP methods have been used for estimating the value of life, comparing these 
values creates an opportunity for testing convergent validity. Focus will be on the RP 
alternative, which can be considered the ‘gold standard’ from the point of view of economics; 
in addition, it has been used more frequently than CV. RP estimates are most often based on 
wage differentials associated with differences in health risks between occupations (Viscusi, 
1992). There is an abundance of such estimates; therefore, the entries of Table 3 are derived 
from four surveys. 
The results of the present study must be made comparable with those shown in Table 3. First, 
calculated WTP is for a reduction of the risk of breaking the femur rather than the risk of 
death. In advance of the choice experiment, it was ascertained that respondents did understand 
the risks associated with a fractured femur. Before making their hypothetical decisions in the 
DCE, respondents were informed about their risk of breaking the femur as well as the 
resulting risk of death. Mortality rates given fracture of the femur were used according to age 
class to estimate the implied relative reduction in mortality due to this particular cause 
(Hubacher and Ewert, 1997; Lippuner et al., 1997). The associated marginal WTP values 
were then integrated for a protective effect of 100 percent which allowed the computation of 
the value of a statistical life, amounting to 1.9 mn. US$ for individuals aged 70 –75. 
 Second, the values cited in Table 3 are based on individuals around forty years of age. On 
theoretical grounds, Shepard and Zeckhauser (1982) predict that the relationship between the 
value of a statistical life and age is inversely U-shaped, with a maximum value around the age 
of forty. This prediction has been empirically confirmed by several authors (Carthy et al., 
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1999; Jones-Lee et al., 1985; Mount et al., 2000). The estimate of the present study is made 
comparable with the international evidence as follows. Its mean value of life of US$ 1.9 mn, 
pertaining to individuals in the 70-75 age bracket, is adjusted to an age of 40 years using the 
empirically found minimum and maximum values of the difference between ages 40 and 70 
of the studies cited. The calculated minimum value amounts to US$ 2.4 mn, the maximum 
value to US$ 4.0 mn. 
 
Table 3 Value of a statistical life, in million US$ (1998 values) a) 
Survey Preferred estimate b) Min Max 
Viscusi (1992) c) 5.1 0.75 24.1 
U.S. Environmental Protection Agency (1999) 6.0 0.75 16.9 
de Blaeij et al. (2000) 2.7 0.15 15.6 
Sommer et al. (1999) 1.4 0.65 5.7 
This study 3.2 2.4 4.0 
a). Value around age 40, see text for details 
b) Value which is preferred by the authors of the survey article  
c) Two studies with extremely low values are not taken into account. 
 
The preferred estimate of US$ 3.2 mn is the average of these two values. It is somewhat lower 
than those from US studies but in keeping with the meta analysis by de Blaeij et al. (2000), 
where European values generally fall short of their US counterparts. As for Switzerland, there 
is one study (Baranzini and Ferro Luzzi, 2001) that is based on RP methods. It comes up with 
a value of statistical life between US$ 6 and 10 mn, which is on the high side when compared 
with the European values given in Sommer et al. (1999). 
Conclusion 2: The age-adjusted WTP results from the present discrete-choice 
experiment study are comparable with other estimates based on revealed 
preference methods, providing preliminary evidence in favor of their 
convergent validity. 
An additional piece of evidence comes from divergent validity, which is the logical 
counterpart of convergent validity, requiring that values of a statistical life should differ if 
they are based on different concepts. Specifically, the human capital approach neglects 
aspects such as pain and suffering that enter the determination of WTP, a difference that may 
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well be of particular importance among individuals of an advanced age. Therefore, the human 
capital approach should result in lower estimates of the value of a statistical life than the WTP 
approach adopted in this study. A study by Buzby et al. (1996) indeed finds a value of US$ 
58,000 (1998 values) for 79-year old individuals (the average age in the present sample), 
which lies far below the US$ 670,000 (at that age) calculated from the results of the present 
study. 
4.3 Criterion validity: actual and stated choice 
Whereas in the preceding section, focus was on estimating MWTP for risk reduction, the 
objective here is to calculate WTP for the specific hip protector HIPS® presented to 
respondents at the end of the experiment. This allows to relate the decision to participate in 
the wearing trial (which is an indicator of actual WTP) to the stated WTP value, amounting to 
a test of criterion validity. Ideally, one would attempt to predict participation in the trial based 
on estimated individual WTP. However, these values derive from utility differences, causing 
socioeconomic characteristics to drop out from the estimating equation unless they enter 
through interactions with product attributes, in particular the cost attribute, permitting 
variation of the marginal utility of income (Johnson and Desvousges, 1997). The present 
sample is limited to individuals aged 70 and more and living independently, resultingin a high 
degree of homogeneity in terms of measured socioeconomic characteristics. This fact may 
explain why these interaction terms did not attain statistical significance, precluding 
calculation of individual WTP values. Even if these values could have been calculated, it is 
doubtful whether predicting the participation decision would have been successful because 
only 16 percent of the sample (83 respondents out of 522) chose to participate in the trial. 
This makes estimation of a distribution function difficult. 
In this situation, prediction has to be replaced by postdiction. The maintained hypothesis is 
that WTP for participants is higher than that of nonparticipants. Therefore, differences in 
WTP values must be calculated for such postdiction,. There are three sources of differences: 
(1) Participants in the trial may rate the product attributes of HIPS® higher; (2) They may put 
a higher MWTP on these attributes; and (3) their WTP for the entire product as the 
combination of attributes may be higher. With regard to (1) attribute levels, note that the 
protective effect (PROT) of HIPS® is set to 100 percent in view of biomechanical studies 
showing that wearing this hip protector completely eliminates the risk of fracture of the femur 
(Denoth, 1998). Similarly, out-of-pocket cost (COST) is equal to zero because the protector 
was offered free of charge for the trial. As to the two remaining attributes, Table 4 suggests 
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that participants indeed rate both ease of handling and wearing comfort of the protector 
HIPS® higher than do nonparticipants; however, the difference is not statistically significant. 
 
Table 4 Rating of product attributes of HIPS® by participants and nonparticipants  
before the wearing trial 
 Participants Nonparticipants 
Product attributes Mean rating Std.dev. b) Mean rating Std.dev. b) 
Protective effect (PROT) a) 100 - 100 - 
Ease of handling (HAND) 2.51 0.67 2.19 0.75 
Wearing comfort (COMF) 2.36 0.63 2.02 0.74 
Out-of-pocket cost (COST) a) 0 - 0 - 
a) Objective value 
b) Standard deviation calculated conservatively using bootstrapping (1,000 repetitions); two alternative methods (Delta, 
Fieller) resulted in smaller values. 
 
With regard to (2) MWTP values for product attributes, the only improvement over the status 
quo is protective effect, whereas even the highest levels of ease of handling and wearing 
comfort still imply a deterioration compared to the status quo. Postdiction therefore amounts 
to saying that the marginal valuation of this one advantage relative to the two disadvantages 
should be higher in the participant group. In Table 5, MWTP for risk reduction (PROT) is 
slightly higher among participants in the trial. In addition, they exhibit significantly lower 
MWTP for the other two attributes than nonparticipants. While this is puzzling, it does imply 
that participants are willing to sacrifice more ease of handling and wearing comfort for a 
given amount of risk reduction than nonparticipants, a difference in marginal rate of 
substitution that accords with expectations. 
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Table 5 Marginal WTP for product attributes of HIPS® among participants and 
nonparticipants, in US$ 
 Participants Nonparticipants 
Product attributes a) Marginal WTP Std.dev. b) Marginal WTP Std.dev. b) 
Protective effect (PROT) 3.35 0.71 3.21 0.59 
Ease of handling (HAND) 56.96 15.25 91.68 16.38 
Wearing comfort (COMF) 122.93 23.59 162.53 23.51 
Correction term -685.84 68.54 -1009.95 55.07 
a) Measured per percentage point in the case of PROT and per unit in the case of HAND and COMF. 
b) Standard deviation calculated conservatively using bootstrapping (1,000 repetitions); two alternative methods (Delta, 
Fieller) resulted in smaller values. 
 
When it comes to (3) calculating mean WTP for HIPS®, MWTP values need to be integrated 
up to the relevant attribute levels and aggregated over attributes (Johnson and Desvousges, 
1997). The higher attribute ratings of participants (taken from Table 4) combine with 
correction terms to overcompensate their lower MWTP for HAND and COMF. Correction 
terms reflecting the different constant terms need to be introduced; they amount to the ratio 
between the estimated constant and the coefficient of the cost attribute from the respective 
random effects probit specification (see Table 2). A negative correction term can be 
interpreted as the reservation price that has to be paid to compensate for the utility loss of 
having to wear a hip protector at all. Such a reservation price mirrors an unfavorable basic 
attitude towards the product in question and is often called status quo bias. One would 
therefore expect the correction term (if negative) to be less marked among participants in the 
trial than nonparticipants. The entries in the bottom row of Table 5 again confirm this 
expectation. 
Calculated in this way, WTP values for HIPS® are displayed in Table 6. They are to be tested 
against zero for the following reason. Participation choices permit to determine upper and 
lower bounds of actual WTP values. For participants the lower bound must be the out-of-
pocket cost (which is zero), while this constitutes the upper bound for nonparticipants. From 
this, one can infer that mean stated WTP should be greater than zero for participants but less 
than zerofor nonparticipants. This expectation is borne out (see Table 6) in that participants 
exhibit a mean value of stated WTP that is significantly positive whereas nonparticipants in 
the wearing trial display a significantly negative WTP on average.  
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One might argue that a higher WTP among participants was to be expected in view of 
Table 5; however, the evidence presented in Table 6 goes beyond this. Indeed, it is the 
postulated indirect utility function that yields the prediction that participants in the wearing 
trial derive more utility from nonprice product attributes than disutility from price. Since price 
is set to zero, their WTP should be positive and nonparticipants’ WTP negative (reflecting 
their negative utility derived from nonprice attributes). Since they confirm the utility 
framework underlying DCE, the results presented in Table 6 thus constitute rather strong 
evidence in favor of DCE having criterion validity. 
 
Table 6 Willingness-to-pay for HIPS® for participants and nonparticipants, in US$ 
 Participants Nonparticipants 
Willingness-to-pay for HIPS® 82.54 -160.07 
Standard deviation a) 12.78 30.69 
T-value (against 0) 6.46 -5.22 
a) Standard deviation calculated conservatively using bootstrapping (1,000 repetitions); two alternative methods (Delta, Fieller) 
resulted in smaller values. 
 
Conclusion 3: Differences between participants and nonparticipants in the wearing trial 
with regard to mean rating of product attributes and marginal WTP 
values for product attributes tend to conform with theoretical 
expectations. Moreover, differences in stated total WTP correspond to 
predicted differences in actual WTP. Taken together, these results 
strongly suggest criterion validity of the discrete-choice experiments 
undertaken. 
As a qualification, it is appropriate to point to the possibility of respondents’ individual 
characteristics (that were not included in the regression for reasons stated at the beginning of 
section 4.3) influencing both their stated WTP and the decision to participate in the wearing 
trial, resulting in a spuriously close correspondence between the two. Therefore, Conclusion 3 
should not be interpreted as claiming a causality running from DCE responses to actual 
choice. 
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5 Summary and conclusion 
Measuring willingness-to-pay (WTP) for health-related goods is of considerable importance 
because the financiers of health – be they governments or health insurers – can use this 
information for matching the provision of health care more closely with the preferences of 
consumers, thus enhancing rationality of decision making in this domain (Zweifel, 2001). 
However, this requires that measurements of WTP are valid in that they adequately reflect 
consumers’ utility. A new and rapidly spreading method is the discrete-choice experiment 
(DCE), where respondents are confronted with product variants differing in attribute levels 
and asked to select the preferred one. Since one of these attributes is cost to the consumer, 
marginal WTP for an attribute can be derived from stated choices. By integrating marginal 
WTP to appropiate levels and aggregating across attributes, total WTP can be calculated as 
well. For all of its attractive features however, one important aspect of DCE has hardly been 
examined to date, viz. its external validity (Conclusion 1). 
The present contribution purports to fill this gap by presenting evidence concerning 
convergent and criterion validity of a DCE involving a hip protector that could reduce the risk 
of fracture of the femur in an elderly Swiss population. Convergent validity requires the 
results of one method to come close to results based on an alternative that is considered valid. 
In this study, the stated WTP for risk reduction was used to derive the value of a statistical 
life, which can be juxtaposed to values based on established alternatives, in particular 
revealed preference. While lower than US estimates, the DCE-based value of a statistical life 
is close to European counterparts, suggesting convergent validity. Conversely, a comparison 
with estimates derived from the human capital method  yields a higher value for the DCE 
alternative, as was to be expected for theoretical reasons (Conclusion 2). 
Criterion validity provides a more powerful test in that it requires stated choices to be related 
to actual choices. The distinguishing feature of the present study is that respondents not only 
made hypothetical choices but also indicated their willingness to participate in a wearing trial, 
which amounts to an actual choice. Ideally, individual WTP values based on DCE should 
serve as predictors of actual choice. However, individual WTP values could not be calculated 
in this sample due to its high degree of homogeneity. This still leaves scope for postdiction in 
that participants should exhibit stated marginal and total WTP values that differ from those of 
nonparticipants. Indeed, among participants the attribute ‘risk reduction’ turns out to be more 
valuable in comparison to ease of handling and wearing comfort than among nonparticipants. 
As to stated total WTP, it should have the price of the product as an upper bound among 
nonparticipants and as a lower bound among participants in the wearing trial. Since price is 
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zero (the trial being offered free of charge), nonparticipants are expected to exhibit negative 
and participants positive stated WTP. This expectation is confirmed as well, providing rather 
strong evidence in favor of DCE having criterion validity (Conclusion 3). 
In all, the tests performed suggest that DCE may have a high degree of external validity even 
in difficult applications. For in this study, respondents were 79 years old on average, and they 
were asked to value risk reductions, i.e. changes in probability, a concept many people have 
difficulty with. On the other hand, at least two qualifications are in order. First, it was not 
possible to use stated WTP values as predictors of individual choices, which often constitutes 
the ultimate objective of such an exercise (Hall et al., 2002). Second, in Swiss health care 
insureds are still used to a degree of cost sharing, which serves to make a decision situation 
involving out-of-pocket cost less hypothetical than in countries with comprehensive coverage 
or a national health service. Therefore, the final verdict about the merits of DCE is not out yet 
when it comes to truly public goods in health care. 
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